How Insurance Covers GLP-1 Medications in 2026
Ozempic, Wegovy, Mounjaro, Zepbound — coverage, prior authorization, and costs explained
Key Takeaways
- GLP-1 coverage for type 2 diabetes (Ozempic, Mounjaro) is much more consistent than for weight management
- Coverage for weight management (Wegovy, Zepbound) varies dramatically — many plans still exclude it
- Prior authorization is required by virtually all plans for GLP-1 medications
- Manufacturer savings programs reduce costs for most commercially insured patients
- BiologicHealthPlus handles all GLP-1 prior authorization and insurance at no charge
GLP-1 Coverage by Indication
| Medication | Indication | Commercial Coverage | Medicare Coverage | Copay Program |
|---|---|---|---|---|
| Ozempic | Type 2 Diabetes | Widely covered with PA | Part D — widely covered | $0–$35/mo |
| Mounjaro | Type 2 Diabetes | Widely covered with PA | Part D — widely covered | $0–$25/mo |
| Wegovy | Weight Management | Variable — many plans exclude | Part D — limited; Advantage varies | $0/mo (eligible) |
| Zepbound | Weight Management | Variable — many plans exclude | Part D — limited; Advantage varies | $0/mo (eligible) |
Why Weight Management GLP-1s Are Harder to Get Covered
Many commercial insurance plans, particularly employer-sponsored plans, have historically excluded obesity medications from their formularies. This has begun to change as clinical evidence for GLP-1 medications in weight management — including cardiovascular risk reduction — has grown substantially.
Medicare Part D traditionally excluded weight loss medications entirely, though the Inflation Reduction Act opened the door to coverage for GLP-1s when indicated for cardiovascular risk reduction (not just weight loss). Medicare Advantage plans have more flexibility and some now cover Wegovy and Zepbound.
Prior Authorization Requirements for GLP-1s
Prior authorization for GLP-1 medications typically requires documentation of:
- For diabetes (Ozempic, Mounjaro): Confirmed type 2 diabetes diagnosis, HbA1c level, current diabetes medications, prescriber specialty
- For weight management (Wegovy, Zepbound): BMI ≥30 (or ≥27 with weight-related comorbidity), documented weight loss attempts, physician-supervised program evidence, absence of contraindications
- Step therapy may require failure of other diabetes medications or documented diet/exercise intervention first
💊 BiologicHealthPlus Handles All GLP-1 Prior Authorization
We manage prior authorization, benefits verification, copay enrollment, and free cold-chain delivery for Ozempic, Wegovy, Mounjaro, and Zepbound.
Check My GLP-1 Coverage →📚 Sources & Further Reading
Content developed with reference to leading health organizations, peer-reviewed research, and FDA prescribing information.
Medical Disclaimer: Educational content reviewed by the BiologicHealthPlus Clinical Team. Consult your healthcare provider for personalized advice. Last reviewed: August 2026.